Načítá se...
Epigenetic and transcriptional profiling of triple negative breast cancer
The human HCC1806 cell line is frequently used as a preclinical model for triple negative breast cancer (TNBC). Given that dysregulated epigenetic mechanisms are involved in cancer pathogenesis, emerging therapeutic strategies target chromatin regulators, such as histone deacetylases. A comprehensiv...
Uloženo v:
| Vydáno v: | Sci Data |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400101/ https://ncbi.nlm.nih.gov/pubmed/30835260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sdata.2019.33 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|